Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-10 @ 9:39 AM
Study NCT ID:
NCT00544167
Status:
COMPLETED
Last Update Posted:
2013-04-01
First Post:
2007-10-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-15
First Submit QC Date:
None
Study First Post Date:
2007-10-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-12-19
Results First Submit QC Date:
None
Results First Post Date:
2013-01-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-25
Last Update Post Date:
2013-04-01
Last Update Post Date Type:
ESTIMATED